Benzinga | Feb 10, 2021 04:30PM EST

Aethlon Medical Q3 EPS $(0.20) Misses $(0.16) Estimate, Sales $624.87M Up From $413.46K YoY

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 28.57 percent increase over losses of $(0.28) per share from the same period last year. The company reported $624.87 million in sales this quarter. This is a 151.03K percent increase over sales of $413.46 thousand the same period last year.